share_log

JonesTrading Upgrades Monopar Therapeutics to Buy, Announces $2 Price Target

Moomoo 24/7 ·  Apr 11 07:39

JonesTrading analyst Soumit Roy upgrades Monopar Therapeutics (NASDAQ:MNPR) from Hold to Buy and announces $2 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment